Takeda Pharmaceutical Co, Japan’s largest drugmaker, agreed to buy Millennium Pharmaceuticals Inc for US$8.8 billion, gaining a blood-cancer medicine before the patent on its best-selling Actos diabetes pill expires in 2011.
Stockholders of Cambridge, Massachusetts-based Millennium will receive US$25 a share in cash, 53 percent more than yesterday’s closing price, the two companies said in a statement today. It is Japan’s largest drug acquisition.
Millennium’s cancer treatment Velcade widens the product pipeline Osaka-based Takeda is developing to buffer sales once Actos faces generic competition. Rival Eisai Co agreed in December to buy US drugmaker MGI Pharma Inc for US$3.9 billion to gain more cancer medicines.
“This deal will boost Takeda’s drug-development flow,” said Mitsuo Ohmi, a Tokyo-based analyst at Japan Advisory LLC. “Millennium is a leader in genome medicine, with some promising drugs in early development.”
The US company generated US$265 million in sales last year from Velcade, which is sold in more than 80 countries. Overall revenue climbed 8 percent to US$528 million. Millennium earned US$14.9 million in net income, its first profit since 1998, according to data compiled by Bloomberg.
Takeda fell 2.5 percent to ¥5,410 on the Tokyo Stock Exchange before the announcement. Millennium gained 41 percent in the past year. The takeover premium is more than double the 23 percent Tokyo-based Eisai paid to acquire MGI Pharma.
Japanese drugmakers are expanding outside the world’s second-largest drug market because domestic growth is hampered by a government policy to cut prescription-medicine prices every two years.
“Millennium has strong discovery, development and commercial capabilities led by a well-established management team,” Takeda president Yasuchika Hasegawa said in the statement. “Takeda is committed to becoming a global leader in oncology.”
‘NO SECURITY RISK’: The Railway Bureau reassured the public that the technicians’ activities were limited to technical guidance and did not involve sensitive systems The Railway Bureau yesterday said it had invited eight Chinese technicians to assist with an airport MRT construction project. The bureau issued the confirmation after an Internet user said Chinese nationals had entered the construction zone of Taiwan Taoyuan International Airport’s Terminal 3 project. They asked why “individuals from an enemy state” were allowed access to such a major national infrastructure project, which raised serious concerns over Taiwan’s industrial safety, sensitive systems and information security. The bureau’s Northern Region Engineering Branch Office said subcontractor Taiwan Handle Industrial Co (台灣手把工業) of the Taoyuan airport MRT’s “Contract No. CU05 Project A14 Station Civil, MEP &
The National Chungshan Institute of Science and Technology yesterday showcased its locally developed variants of the Vision 60 robotic patrol dog, which it plans to deploy on the nation’s outlying territories in the South China Sea. The variants were produced under the Joint Lab project — created by the institute and domestic companies — and assembled with domestically produced motors, lenses and artificial intelligence (AI) systems alongside licensed tech from the US, Missile and Rocket Systems Research Division deputy director Jen Kuo-kang (任國光) told the media event at a military base in Taipei’s Dazhi (大直) area. Taiwan has built up its strengths
TIT-FOR-TAT: The US allegedly revoked the visa of a Chinese national working at Xinhua News Agency in the US in response to Beijing’s expulsion of Vivian Wang The Presidential Office yesterday condemned China for expelling a New York Times correspondent from Beijing following the newspaper’s interview with President William Lai (賴清德), saying the move highlighted Beijing’s suppression of press freedom and its threat to international news media. Taiwan has noted a series of recent incidents in which Beijing used similar tactics to “threaten and pressure international media outlets and journalists,” Presidential Office spokeswoman Karen Kuo (郭雅慧) said in a statement. “This concerns not only press freedom and freedom of expression, but also the safety of journalists, and Taiwan and relevant partners are paying close attention to the situation,” she
NOT IMMEDIATE: Taiwan has a chance to appeal the proposed 10 percent tariff before it starts, while other countries face a 12.5 percent tariff from the trade office Taiwan is among 60 economies determined by the US to have failed to impose or enforce a ban on the importation of goods produced with forced labor, according to a notice released on Tuesday by the Office of the US Trade Representative (USTR), which proposed imposing an additional 10 percent or more tariff on them. The USTR in a statement said that following an investigation, it had determined under Section 301 of the Trade Act of 1974 that the failure of the 60 economies to impose and effectively enforce a prohibition on the importation of goods produced with forced labor is
RSS